| 000 | 02609 a2200685 4500 | ||
|---|---|---|---|
| 005 | 20250514233308.0 | ||
| 264 | 0 | _c20051223 | |
| 008 | 200512s 0 0 eng d | ||
| 022 | _a1019-6439 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCoudray, Anne-Marie | |
| 245 | 0 | 0 |
_aIncreased anticancer activity of the thymidylate synthase inhibitor BGC9331 combined with the topoisomerase I inhibitor SN-38 in human colorectal and breast cancer cells: induction of apoptosis and ROCK cleavage through caspase-3-dependent and -independent mechanisms. _h[electronic resource] |
| 260 |
_bInternational journal of oncology _cAug 2005 |
||
| 300 |
_a553-61 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aBreast Neoplasms _xmetabolism |
| 650 | 0 | 4 |
_aCamptothecin _xanalogs & derivatives |
| 650 | 0 | 4 | _aCaspase 3 |
| 650 | 0 | 4 | _aCaspase Inhibitors |
| 650 | 0 | 4 |
_aCaspases _xmetabolism |
| 650 | 0 | 4 |
_aCell Cycle _xdrug effects |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aColorectal Neoplasms _xmetabolism |
| 650 | 0 | 4 |
_aCysteine Proteinase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aDNA Topoisomerases, Type I _xmetabolism |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aFluorouracil _xpharmacology |
| 650 | 0 | 4 |
_aFolic Acid Antagonists _xpharmacology |
| 650 | 0 | 4 |
_aGlutamates _xpharmacology |
| 650 | 0 | 4 |
_aGuanine _xanalogs & derivatives |
| 650 | 0 | 4 | _aHT29 Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIntracellular Signaling Peptides and Proteins |
| 650 | 0 | 4 | _aIrinotecan |
| 650 | 0 | 4 |
_aOligopeptides _xpharmacology |
| 650 | 0 | 4 |
_aOrganoplatinum Compounds _xpharmacology |
| 650 | 0 | 4 | _aOxaliplatin |
| 650 | 0 | 4 | _aPemetrexed |
| 650 | 0 | 4 |
_aProtein Serine-Threonine Kinases _xmetabolism |
| 650 | 0 | 4 |
_aQuinazolines _xpharmacology |
| 650 | 0 | 4 |
_aThymidylate Synthase _xantagonists & inhibitors |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTopoisomerase I Inhibitors |
| 650 | 0 | 4 | _arho-Associated Kinases |
| 700 | 1 | _aLouvet, Christophe | |
| 700 | 1 | _aKornprobst, Michel | |
| 700 | 1 | _aRaymond, Eric | |
| 700 | 1 | _aAndré, Thierry | |
| 700 | 1 | _aTournigand, Christophe | |
| 700 | 1 | _aFaivre, Sandrine | |
| 700 | 1 | _aDe Gramont, Aimery | |
| 700 | 1 | _aLarsen, Annette K | |
| 700 | 1 | _aGespach, Christian | |
| 773 | 0 |
_tInternational journal of oncology _gvol. 27 _gno. 2 _gp. 553-61 |
|
| 999 |
_c15666402 _d15666402 |
||